{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T16:44:43Z","timestamp":1783529083247,"version":"3.55.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T00:00:00Z","timestamp":1661126400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T00:00:00Z","timestamp":1661126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100005795","name":"Chang Gung Memorial Hospital, Linkou","doi-asserted-by":"publisher","award":["CORPG3J0061"],"award-info":[{"award-number":["CORPG3J0061"]}],"id":[{"id":"10.13039\/501100005795","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BioDrugs"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1007\/s40259-022-00547-5","type":"journal-article","created":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T13:05:36Z","timestamp":1661173536000},"page":"657-666","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Real-World Effects of Biologics on Renal Function in Psoriatic Patients: A Retrospective Study"],"prefix":"10.1007","volume":"36","author":[{"given":"Chun-Bing","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Tung","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Chung","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shang-Hung","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5699-0283","authenticated-orcid":false,"given":"Ching-Chi","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,22]]},"reference":[{"issue":"2","key":"547_CR1","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/jid.2012.339","volume":"133","author":"R Parisi","year":"2013","unstructured":"Parisi R, Symmons DP, Griffiths CE, Ashcroft DM. Identification, Management of P, et al. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol. 2013;133(2):377\u201385.","journal-title":"J Invest Dermatol"},{"issue":"4","key":"547_CR2","doi-asserted-by":"publisher","first-page":"199","DOI":"10.4103\/ds.ds_42_20","volume":"38","author":"F Kemeriz","year":"2020","unstructured":"Kemeriz F, Tu\u011frul B, Tuncer S. C-reactive protein to albumin ratio: Is a new parameter for the disease severity in patients with psoriasis vulgaris? Dermatol Sin. 2020;38(4):199\u2013204.","journal-title":"Dermatol Sin"},{"issue":"3","key":"547_CR3","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1111\/j.1365-2133.2010.09941.x","volume":"163","author":"K Abuabara","year":"2010","unstructured":"Abuabara K, Azfar RS, Shin DB, Neimann AL, Troxel AB, Gelfand JM. Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U.K. Br J Dermatol. 2010;163(3):586\u201392.","journal-title":"Br J Dermatol"},{"issue":"1","key":"547_CR4","doi-asserted-by":"publisher","first-page":"22","DOI":"10.4103\/ds.ds_33_19","volume":"38","author":"TP Fang","year":"2020","unstructured":"Fang TP, Lin YC, Chi CC. Association of psoriasis with asthma: a systematic review and meta-analysis of observational studies. Dermatol Sin. 2020;38(1):22\u20137.","journal-title":"Dermatol Sin"},{"issue":"2","key":"547_CR5","doi-asserted-by":"publisher","first-page":"81","DOI":"10.4103\/ds.ds_35_19","volume":"38","author":"O Demirci","year":"2020","unstructured":"Demirci O, Ates B, Sagaltici E, Ocak Z, Altunay I. Association of the attachment styles with depression, anxiety, and quality of life in patients with psoriasis. Dermatol Sin. 2020;38(2):81\u20137.","journal-title":"Dermatol Sin"},{"issue":"Suppl 2","key":"547_CR6","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/j.1365-2133.2008.08780.x","volume":"159","author":"F Spah","year":"2008","unstructured":"Spah F. Inflammation in atherosclerosis and psoriasis: common pathogenic mechanisms and the potential for an integrated treatment approach. Br J Dermatol. 2008;159(Suppl 2):10\u20137.","journal-title":"Br J Dermatol"},{"issue":"3","key":"547_CR7","doi-asserted-by":"publisher","first-page":"166","DOI":"10.4103\/ds.ds_27_20","volume":"38","author":"CY Ng","year":"2020","unstructured":"Ng CY, Huang YH, Tzeng IS, Liu SH, Chang YC. Changes in metabolic parameters in psoriasis patients treated with interleukin-12\/23 blockade (ustekinumab). Dermatol Sin. 2020;38(3):166\u201371.","journal-title":"Dermatol Sin"},{"key":"547_CR8","doi-asserted-by":"crossref","unstructured":"Puig L. Cardiometabolic comorbidities in psoriasis and psoriatic arthritis. Int J Mol Sci. 2017;19(1):58.","DOI":"10.3390\/ijms19010058"},{"issue":"4","key":"547_CR9","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1093\/ndt\/gfn604","volume":"24","author":"W Chen","year":"2009","unstructured":"Chen W, Chen W, Wang H, Dong X, Liu Q, Mao H, et al. Prevalence and risk factors associated with chronic kidney disease in an adult population from southern China. Nephrol Dial Transplant. 2009;24(4):1205\u201312.","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"547_CR10","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1159\/000247420","volume":"185","author":"R Cecchi","year":"1992","unstructured":"Cecchi R, Seghieri G, Gironi A, Tuci F, Giomi A. Relation between urinary albumin excretion and skin involvement in patients with psoriasis. Dermatology. 1992;185(2):93\u20135.","journal-title":"Dermatology"},{"issue":"6","key":"547_CR11","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1046\/j.1468-3083.2000.00119.x","volume":"14","author":"JC Szepietowski","year":"2000","unstructured":"Szepietowski JC, Bielicka E, Wasik F, Kopec W, Szepietowski T. Microalbuminuria as a subclinical marker of renal impairment in subjects with psoriasis vulgaris. J Eur Acad Dermatol Venereol. 2000;14(6):513\u20134.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"547_CR12","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s11255-011-9966-1","volume":"44","author":"E Dervisoglu","year":"2012","unstructured":"Dervisoglu E, Akturk AS, Yildiz K, Kiran R, Yilmaz A. The spectrum of renal abnormalities in patients with psoriasis. Int Urol Nephrol. 2012;44(2):509\u201314.","journal-title":"Int Urol Nephrol"},{"issue":"5","key":"547_CR13","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1111\/j.1365-2133.2011.10494.x","volume":"165","author":"YW Yang","year":"2011","unstructured":"Yang YW, Keller JJ, Lin HC. Medical comorbidity associated with psoriasis in adults: a population-based study. Br J Dermatol. 2011;165(5):1037\u201343.","journal-title":"Br J Dermatol"},{"key":"547_CR14","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f5961","volume":"347","author":"J Wan","year":"2013","unstructured":"Wan J, Wang S, Haynes K, Denburg MR, Shin DB, Gelfand JM. Risk of moderate to advanced kidney disease in patients with psoriasis: population based cohort study. BMJ. 2013;347: f5961.","journal-title":"BMJ"},{"issue":"3","key":"547_CR15","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.jdermsci.2015.03.012","volume":"78","author":"CC Chi","year":"2015","unstructured":"Chi CC, Wang J, Chen YF, Wang SH, Chen FL, Tung TH. Risk of incident chronic kidney disease and end-stage renal disease in patients with psoriasis: a nationwide population-based cohort study. J Dermatol Sci. 2015;78(3):232\u20138.","journal-title":"J Dermatol Sci"},{"issue":"1","key":"547_CR16","doi-asserted-by":"publisher","first-page":"19","DOI":"10.4103\/ds.ds_48_20","volume":"39","author":"SF Yang","year":"2021","unstructured":"Yang SF, Chen TH, Tsai SH, Chen PE, Chi CC, Tung TH. Risk of chronic kidney disease and end-stage renal disease in patients with psoriasis: a systematic review and meta-analysis of cohort studies. Dermatol Sin. 2021;39(1):19\u201326.","journal-title":"Dermatol Sin"},{"key":"547_CR17","doi-asserted-by":"crossref","unstructured":"Krebs CF, Turner JE, Riedel JH, Panzer U. Tissue-specific therapy in immune-mediated kidney diseases: new ARGuments for targeting the IL-23\/IL-17 axis. J Clin Invest. 2021;131(12):e150588.","DOI":"10.1172\/JCI150588"},{"key":"547_CR18","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.3389\/fphar.2019.01192","volume":"10","author":"V Andrade-Oliveira","year":"2019","unstructured":"Andrade-Oliveira V, Foresto-Neto O, Watanabe IKM, Zatz R, Camara NOS. Inflammation in renal diseases: new and old players. Front Pharmacol. 2019;10:1192.","journal-title":"Front Pharmacol"},{"issue":"4","key":"547_CR19","doi-asserted-by":"publisher","first-page":"F1005","DOI":"10.1152\/ajprenal.00535.2016","volume":"313","author":"E Mehaffey","year":"2017","unstructured":"Mehaffey E, Majid DSA. Tumor necrosis factor-alpha, kidney function, and hypertension. Am J Physiol Renal Physiol. 2017;313(4):F1005\u20138.","journal-title":"Am J Physiol Renal Physiol"},{"key":"547_CR20","doi-asserted-by":"crossref","unstructured":"Li H, Tsokos MG, Bhargava R, Adamopoulos IE, Menn-Josephy H, Stillman IE, et al. IL-23 reshapes kidney resident cell metabolism and promotes local kidney inflammation. J Clin Invest. 2021;131(12):e142428.","DOI":"10.1172\/JCI142428"},{"issue":"12","key":"547_CR21","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.1681\/ASN.2021030426","volume":"32","author":"T Schmidt","year":"2021","unstructured":"Schmidt T, Luebbe J, Kilian C, Riedel JH, Hiekmann S, Asada N, et al. IL-17 receptor C signaling controls CD4(+) TH17 immune responses and tissue injury in immune-mediated kidney diseases. J Am Soc Nephrol. 2021;32(12):3081\u201398.","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"547_CR22","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/j.jaad.2019.12.043","volume":"82","author":"J Maghfour","year":"2020","unstructured":"Maghfour J, Elliott E, Gill F, Stumpf B, Murina A. Effect of biologic drugs on renal function in psoriasis patients with chronic kidney disease. J Am Acad Dermatol. 2020;82(5):1249\u201351.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"547_CR23","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.bj.2017.08.002","volume":"40","author":"MS Tsai","year":"2017","unstructured":"Tsai MS, Lin MH, Lee CP, Yang YH, Chen WC, Chang GH, et al. Chang Gung Research Database: A multi-institutional database consisting of original medical records. Biomed J. 2017;40(5):263\u20139.","journal-title":"Biomed J"},{"issue":"5","key":"547_CR24","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1002\/pds.4713","volume":"28","author":"SC Shao","year":"2019","unstructured":"Shao SC, Chan YY, Kao Yang YH, Lin SJ, Hung MJ, Chien RN, et al. The Chang Gung Research Database-A multi-institutional electronic medical records database for real-world epidemiological studies in Taiwan. Pharmacoepidemiol Drug Saf. 2019;28(5):593\u2013600.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"9","key":"547_CR25","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1111\/ijd.12462","volume":"53","author":"SH Wang","year":"2014","unstructured":"Wang SH, Chi CC, Hu S. Cost-efficacy of biologic therapies for moderate to severe psoriasis from the perspective of the Taiwanese healthcare system. Int J Dermatol. 2014;53(9):1151\u20136.","journal-title":"Int J Dermatol"},{"issue":"2","key":"547_CR26","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.dsi.2017.01.002","volume":"35","author":"TF Tsai","year":"2017","unstructured":"Tsai TF, Lee CH, Huang YH, Chi CC, Chang YT, Wong TW, et al. Taiwanese Dermatological Association consensus statement on management of psoriasis. Dermatol Sin. 2017;35(2):66\u201377.","journal-title":"Dermatol Sin"},{"issue":"4","key":"547_CR27","doi-asserted-by":"publisher","first-page":"247","DOI":"10.7326\/0003-4819-145-4-200608150-00004","volume":"145","author":"AS Levey","year":"2006","unstructured":"Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145(4):247\u201354.","journal-title":"Ann Intern Med"},{"issue":"12","key":"547_CR28","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1038\/sj.ki.5001875","volume":"70","author":"K Uhlig","year":"2006","unstructured":"Uhlig K, Macleod A, Craig J, Lau J, Levey AS, Levin A, et al. Grading evidence and recommendations for clinical practice guidelines in nephrology. A position statement from Kidney Disease: improving Global Outcomes (KDIGO). Kidney Int. 2006;70(12):2058\u201365.","journal-title":"Kidney Int"},{"issue":"1 suppl","key":"547_CR29","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1177\/0300060515613495","volume":"44","author":"P Gisondi","year":"2016","unstructured":"Gisondi P, Girolomoni G. Glomerular filtration rate in patients with psoriasis treated with etanercept. J Int Med Res. 2016;44(1 suppl):106\u20138.","journal-title":"J Int Med Res"},{"issue":"6","key":"547_CR30","doi-asserted-by":"publisher","first-page":"e244","DOI":"10.1111\/jdv.15506","volume":"33","author":"P Gisondi","year":"2019","unstructured":"Gisondi P, Pezzolo E, Girolomoni G. Glomerular filtration rate in patients with moderate-to-severe psoriasis. J Eur Acad Dermatol Venereol. 2019;33(6):e244\u20136.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"7","key":"547_CR31","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1136\/ard.2006.069211","volume":"66","author":"AJ Hueber","year":"2007","unstructured":"Hueber AJ, Tunc A, Schett G, Manger B. Anti-tumour necrosis factor alpha therapy in patients with impaired renal function. Ann Rheum Dis. 2007;66(7):981\u20132.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"547_CR32","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/1346-8138.12989","volume":"43","author":"K Nimmannitya","year":"2016","unstructured":"Nimmannitya K, Tateishi C, Mizukami Y, Hamamoto K, Yamada S, Goto H, et al. Successful treatment with ustekinumab of psoriasis vulgaris in a patient undergoing hemodialysis. J Dermatol. 2016;43(1):92\u20134.","journal-title":"J Dermatol"},{"issue":"6","key":"547_CR33","first-page":"46","volume":"12","author":"D Mikhaylov","year":"2019","unstructured":"Mikhaylov D, Hashim PW, Nektalova T, Goldenberg G. Systemic psoriasis therapies and comorbid disease in patients with psoriasis: a review of potential risks and benefits. J Clin Aesthet Dermatol. 2019;12(6):46\u201354.","journal-title":"J Clin Aesthet Dermatol."},{"key":"547_CR34","doi-asserted-by":"crossref","unstructured":"Ikonomidis I, Papadavid E, Makavos G, Andreadou I, Varoudi M, Gravanis K, et al. Lowering interleukin-12 activity improves myocardial and vascular function compared with tumor necrosis factor-a antagonism or cyclosporine in psoriasis. Circ Cardiovasc Imaging. 2017;10(9):e006283.","DOI":"10.1161\/CIRCIMAGING.117.006283"},{"issue":"1","key":"547_CR35","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.cjca.2019.06.021","volume":"36","author":"G Makavos","year":"2020","unstructured":"Makavos G, Ikonomidis I, Andreadou I, Varoudi M, Kapniari I, Loukeri E, et al. Effects of interleukin 17a inhibition on myocardial deformation and vascular function in psoriasis. Can J Cardiol. 2020;36(1):100\u201311.","journal-title":"Can J Cardiol"},{"issue":"3","key":"547_CR36","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.pathol.2017.01.003","volume":"49","author":"C Cortvrindt","year":"2017","unstructured":"Cortvrindt C, Speeckaert R, Moerman A, Delanghe JR, Speeckaert MM. The role of interleukin-17A in the pathogenesis of kidney diseases. Pathology. 2017;49(3):247\u201358.","journal-title":"Pathology"},{"issue":"6","key":"547_CR37","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1016\/j.kint.2018.12.031","volume":"95","author":"C Lavoz","year":"2019","unstructured":"Lavoz C, Matus YS, Orejudo M, Carpio JD, Droguett A, Egido J, et al. Interleukin-17A blockade reduces albuminuria and kidney injury in an accelerated model of diabetic nephropathy. Kidney Int. 2019;95(6):1418\u201332.","journal-title":"Kidney Int"},{"issue":"5","key":"547_CR38","doi-asserted-by":"publisher","first-page":"543","DOI":"10.3390\/healthcare9050543","volume":"9","author":"GF Amoruso","year":"2021","unstructured":"Amoruso GF, Nistico SP, Iannone L, Russo E, Rago G, Patruno C, et al. Ixekizumab may improve renal function in psoriasis. Healthcare (Basel). 2021;9(5):543.","journal-title":"Healthcare (Basel)."},{"issue":"3","key":"547_CR39","first-page":"406","volume":"156","author":"S Ribero","year":"2021","unstructured":"Ribero S, Conti V, Gambardella A, Der AB, Dapavo P, Argenziano G. Brodalumab treatment in psoriasis patients with severe renal failure. Ital J Dermatol Venerol. 2021;156(3):406\u20138.","journal-title":"Ital J Dermatol Venerol."},{"key":"547_CR40","doi-asserted-by":"crossref","unstructured":"Mastorino L, Roccuzzo G, Dapavo P, Siliquini N, Avallone G, Rubatto M, et al. Patients with psoriasis resistant to multiple biological therapies: characteristics and definition of a difficult-to-treat population. Br J Dermatol. 2022;187(2):263\u20135.","DOI":"10.1111\/bjd.21048"}],"container-title":["BioDrugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40259-022-00547-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40259-022-00547-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40259-022-00547-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T11:07:00Z","timestamp":1663585620000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40259-022-00547-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,22]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["547"],"URL":"https:\/\/doi.org\/10.1007\/s40259-022-00547-5","relation":{},"ISSN":["1173-8804","1179-190X"],"issn-type":[{"value":"1173-8804","type":"print"},{"value":"1179-190X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,22]]},"assertion":[{"value":"24 July 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was supported by research grants from the Chang Gung Memorial Hospital, Linkou, Taiwan (CORPG3J0061). The funder played no role in study design, data collection, data analysis, manuscript preparation, and publication decisions.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The data used for this study are available from the corresponding author on reasonable request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability statement"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This study was approved by the Institutional Review Board of Chang Gung Medical Foundation (IRB. NO. 201802089B0C502).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability:"}},{"value":"CBC, TYH, CCH, SHC, and CCC had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Study concept and design: CBC, CCH, SHC, and CCC. Acquisition, analysis, or interpretation of data: All authors. Drafting of the manuscript: CBC, TYH, CCH, and CCC. Critical revision of the manuscript for important intellectual content: All authors. Statistical analysis: CBC, TYH, SHC, and CCC. Obtained funding: SHC, and CCC. Study supervision: CCC.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}